Park Ha Biological Technology Co
BYAH
12 hedge funds and large institutions have $4.03M invested in Park Ha Biological Technology Co in 2025 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.
505% more capital invested
Capital invested by funds: $666K → $4.03M (+$3.36M)
400% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 2
200% more funds holding
Funds holding: 4 → 12 (+8)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$349K |
| 2 |
BNP Paribas Financial Markets
Paris,
France
|
+$202K |
| 3 |
SOW
State of Wyoming
Cheyenne,
Wyoming
|
+$202K |
| 4 |
SRL
Scientech Research LLC
Jersey City,
New Jersey
|
+$141K |
| 5 |
Morgan Stanley
New York
|
+$121K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$195K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$40.3K |
BYAH Hedge Fund Activity: Q2 2025 in Review
12 of the 7,598 institutional investors tracked by Wall St. Rank reported a position in Park Ha Biological Technology Co (BYAH) for Q2 2025, worth a combined $4.03M — up 505% from $666K a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new BYAH positions and 2 closed out — a net gain of 8 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Invesco, opening a new position worth an estimated $349K. The largest seller was HRT Financial, exiting entirely with an estimated $195K sold.
- 12 institutional investors held Park Ha Biological Technology Co (BYAH) as of Q2 2025, up from 4 in Q1 2025.
- Funds reported $4.03M of Park Ha Biological Technology Co stock for Q2 2025, up 505% quarter-over-quarter.
- 10 funds opened new Park Ha Biological Technology Co positions in Q2 2025 and 2 closed out, a net change of +8 holders.
- The largest Park Ha Biological Technology Co buyer in Q2 2025 was Invesco, an estimated $349K added.
- The largest Park Ha Biological Technology Co seller in Q2 2025 was HRT Financial, an estimated $195K sold.
Based on aggregated 13F filings for Q2 2025.